KL-6, a mucinous glycoprotein, as an indicator of chronic lung disease of the newborn.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 10931429.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
KL-6 is a mucinous glycoprotein that is preferentially expressed by alveolar type 2 cells. Plasma KL-6 was higher in infants with chronic lung disease (n = 12) than in infants without chronic lung disease (n = 14) on day 0-1, 10, and 30 (P =.04). KL-6 correlated with the alveolar-arterial oxygen tension difference on day 10 and day 30. Plasma KL-6 may be useful as an early marker of chronic lung disease and an indicator of severity.
Medical subject headings
- Antigens
- Bronchopulmonary Dysplasia
- Glycoproteins
- Infant, Premature
- Mucins
- Peptide Fragments
- Procollagen